SCHEMBL30830674

SCHEMBL30830674

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(CN3CCN(c4ccc5c(c4)CN(C4CCC(=O)NC4=O)C5=O)CC3)cc2)C1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ IKZF2 Q9UKS7 12/20 0.49
▸ KAT2B Q92831 2/20 0.48
▸ BRD9 Q9H8M2 2/20 0.48
▸ BRD1 O95696 1/20 0.48
▸ ACHE P22303 1/20 0.48
▸ BRPF1 P55201 1/20 0.48
▸ BPTF Q12830 1/20 0.48
▸ KAT2A Q92830 1/20 0.48
▸ BRD7 Q9NPI1 1/20 0.48
▸ BAZ2B Q9UIF8 1/20 0.48
▸ BRPF3 Q9ULD4 1/20 0.48
▸ IKZF1 Q13422 5/20 0.44
▸ WIZ O95785 1/20 0.42
▸ CRBN Q96SW2 1/20 0.41
▸ IKZF3 Q9UKT9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831120 0.95 IKZF2 (0.51) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30830574 0.93 IKZF2 (0.49) IKZF2KAT2BBRD9IKZF1CRBN
SCHEMBL30830607 0.93 IKZF2 (0.59) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30830800 0.92 IKZF2 (0.52) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30830749 0.91 IKZF2 (0.55) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30830707 0.90 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830927 0.89 IKZF2 (0.47) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30831095 0.89 KAT2B (0.48) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30831116 0.89 KAT2B (0.47) IKZF2KAT2BBRD9BRD1ACHE
SCHEMBL30830526 0.88 IKZF2 (0.52) IKZF2KAT2BBRD9IKZF1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback